The Country Caller takes a dig at the upcoming earnings of Priceline Group & CVS Health ahead of their Q3 announcements
This earnings season, Priceline Group Inc (NASDAQ:PCLN) and CVS Health Corp (NYSE:CVS) are all set to report their financials for the third quarter of fiscal year 2016. According to earningswhispers.com and Estimize, both the companies are expected to beat the Street on both top and bottom lines. The Country Caller discusses the whisper numbers in detail below.
The consensus expects $29.92 in EPS for the Q3 of PCLN. This hints toward a 18.02% annual rise as the company reported $25.35 in EPS for the same quarter last year. For the preceding quarter, Priceline reported $13.93 in EPS, which suggests that the consensus expects 29.92% sequential growth in earnings. According to earningswhisper.com’s estimate, the company would beat the Street on bottom line by one cent at $29.93 EPS.
For 3QFY16, the consensus projects PCLN to report $3.62 billion in revenues. This estimate reflects a YoY growth of 16.77% as the company reported $3.10 billion revenue a year ago for the same period. Whereas, according to last quarter sales of $2.55 billion, the consensus is looking for a 41.96% rise in sales. However, Estimize’s estimate of $3.628 billion revenue suggests that the company will beat the Street on top line slightly.
CVS Health Corp
For the quarter ended September 30, EarningsWhispers.com expects CVS to report earnings of $1.59 per share, suggesting the company to beat the Street’s estimate of $1.57 EPS. A year ago earnings of $1.28 per share reflects a YoY increase of 22.65%. For the preceding quarter, the company reported $1.22 in EPS.
The consensus anticipates CVS’ revenue to come in at $45.31 billion, which is slightly below Estimize’s projection of $45.336 billion. That would be 17.38% higher than its revenue of $38.6 billion a year ago. For 2QFY16, revenue came in at $37.2 billion, which implies a 21.80% QoQ rise in revenue this quarter.